Economic Atlas
Companies/Hyperfine, Inc.
Company profile

Hyperfine, Inc.

NASDAQ: HYPR · Healthcare · Medical - Devices
PublicHQ Guilford, CTCIK 0001833769Reports USD
#593 of 1,418 Healthcare companies by revenue49th-percentile growth
EA Score
44D
Revenue TTM
$15.3M
Rev growth YoY (TTM)
+30.7%
Net income (FY)
-$35.6M
Employees
102
as of 2026-08-18
Market cap
$75.9M
as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$13.6M$13.6M2025
Net income-$35.6M-$35.6M2025
Operating income-$37.1M-$37.1M2025
Total assets$55.3M$55.3M2025
Liabilities$14.3M$14.3M2025
Equity$41.0M$41.0M2025

Revenue trend

FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product84%
Service16%
By geography
Non-US100%
The read

What is Hyperfine, Inc.’s revenue?

Hyperfine, Inc. booked $13.6M in FY2025 revenue, growing 5.2% year over year — about the middle of the pack among Healthcare companies we track, at a -262.3% net margin.

Peers · Healthcare
Pyxis Oncology, Inc.28DBiotricity, Inc.——CV Sciences, Inc.56CCapsoVision, Inc.37DMicrobix Biosystems Inc.60CNovo Integrated Sciences, Inc.——
Key facts
CEOMaria Degois Sainz
SectorHealthcare
IndustryMedical - Devices
HeadquartersGuilford, CT
ExchangeNASDAQ: HYPR
Employees102
IPO date2021-01-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.